Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer

Karolina Boman(Lund University), Karin Jirström(Lund University)

British Journal of Cancer

May 7, 2013

10.1038/bjc.2013.215

Cited by 75

Related Papers

Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer

|Modern Pathology|2009|85

The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinoma

|Oncotarget|2017|62

Expression of PD-L1 and PD-1 in Chemoradiotherapy-Naïve Esophageal and Gastric Adenocarcinoma: Relationship With Mismatch Repair Status and Survival

|Frontiers in Oncology|2019|45

Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study

|Biomarker Research|2017|18

Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: longitudinal expression, transcriptome-level effects and modulation of chemosensitivity

|BMC Cancer|2022|6